Petmed Express (PETS) Stock Price
Petmed Express Price
Revenue has compounded at 0.5% per year over the past 19 years to 179.02 M USD. Earnings per share have declined at 5.4% per year over the last 16 years. Petmed Express's net margin stands at -32.0%, down from 7.7% several years earlier. Petmed Express currently offers a dividend yield of about 49.18%. The payout ratio is around 195% of earnings. The dividend has grown at 7.6% per year over the past 15 years. Analysts set a median price target of 2.81 USD, implying 129.9% above the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.
Petmed Express stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Petmed Express business model & stock analysis
Frequently asked questions about Petmed Express
The business model of Petmed Express Inc. is focused on providing convenient and affordable pet medications and veterinary products directly to pet owners. Petmed Express operates through its website and a toll-free customer service center, allowing customers to easily order prescription and non-prescription medications, as well as other pet supplies. The company also offers free shipping on orders over a certain amount, further enhancing its value proposition to customers. By streamlining the process of obtaining pet medications, Petmed Express aims to offer a cost-effective solution for pet owners, ultimately promoting the health and well-being of their beloved pets.
Petmed Express Inc, commonly known as PetMeds, primarily operates within the pet care industry. As a leading online pet pharmacy, Petmed Express Inc focuses on the distribution of prescription and non-prescription pet medications, as well as other health and wellness products for pets. With its wide range of offerings, Petmed Express Inc serves as a one-stop destination for pet owners seeking convenient access to pet supplies. While primarily active in the pet care sector, Petmed Express Inc contributes to the overall animal health industry by providing medications and products that support the well-being of beloved companions.
The main competitors of PetMed Express Inc in the market include companies like Chewy Inc, 1-800-PetMeds, and Petco Animal Supplies Inc.
Petmed Express Inc, commonly known as PetMeds, is a leading online pet pharmacy in the United States. Established in 1996, PetMeds has a rich history of providing convenient and affordable pet medications and supplies to pet owners across the country. With a focus on delivering exceptional customer service and high-quality products, PetMeds has built a strong reputation in the pet healthcare industry. Over the years, the company has grown exponentially and has become a trusted name among pet owners, offering a wide range of prescription and non-prescription medications, as well as pet accessories and supplements. PetMeds continues to thrive as a reliable online destination for pet health needs.
Petmed Express Inc has achieved several significant milestones throughout its history. The company has consistently delivered quality pet medications and supplies across the United States. It has established a strong presence in the online pet pharmacy market, catering to the increasing demand for convenient and cost-effective pet care products. Petmed Express Inc has diligently grown its customer base and created a loyal following by providing exceptional customer service. The company's commitment to pet health and wellbeing has been recognized through numerous industry awards and accolades. Overall, Petmed Express Inc has successfully carved a niche for itself in the pet pharmaceutical industry, solidifying its position as a reliable and trusted provider of pet medications and related products.
Petmed Express Inc, also known as 1-800-PetMeds, primarily operates in the United States. As a leading provider of pet medications, the company serves customers across all regions and states within the US. With a comprehensive online platform, Petmed Express Inc offers convenient access to a wide range of affordable prescription and over-the-counter pet medications, catering to the needs of pet owners nationwide. By focusing on the US market, Petmed Express Inc has established itself as a trusted and reliable destination for pet medication needs, ensuring the well-being of pets across the country.
Petmed Express Inc represents values of customer-centric service, trust, and quality in the pet medication industry. With a commitment to providing affordable and convenient pet medications, Petmed Express aims to ensure the well-being of pets and satisfaction of their owners. The company's corporate philosophy revolves around delivering exceptional healthcare solutions for pets, emphasizing personalized care and easy accessibility. Petmed Express prioritizes transparency, reliability, and professionalism in all its operations, striving to establish long-term relationships with customers based on trust and ethical practices.
Analysts currently set an average price target of 2.81 USD for the Petmed Express stock (median: 2.81 USD), implying +129.9 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Petmed Express stock: 0 recommend buying, 2 holding and 4 selling.
Converted at the current exchange rate, the Petmed Express share trades at 1.09 EUR (1.22 USD).
The Petmed Express share (PETS) is listed on 5 stock exchanges, including: NASDAQ (PETS), SIX (Zürich) (PQM.SW), Frankfurt (PQM.F), München (PQM.MU), Düsseldorf (PQM.DU).
Petmed Express Inc is a publicly traded company that has been successfully operating in the online trade of veterinary medicines since 1996. The company is known under the names "PetMeds" and "1800PetMeds". The business model of Petmed Express is based on selling animal medications and products through the internet and phone. Customers have the opportunity to purchase a variety of products for dogs, cats, and other animals, including prescription medications, supplements, vaccines, and other health products. The company focuses on products prescribed by veterinarians. Petmed Express offers its customers a range of benefits, including fast delivery, free shipping on orders over $49.95, a loyalty program, and an easy return and refund policy. The company is also committed to offering customers the best price in the market and regularly provides special offers and discount codes. An important part of Petmed Express' business model is collaborating with veterinarians. They can refer customers to the company and receive a commission in return. The company also works with various animal organizations to support animal welfare and rescue efforts. Petmed Express also has a division called "Vetmedin" that specializes in marketing Vetmedin®, a medication for treating heart failure in dogs. This medication is only available with a prescription, and the company works closely with veterinarians to provide it to affected dogs. Another important aspect of Petmed Express is the brand "Frontline". The company is the exclusive online distribution partner for Frontline® products in the United States. Frontline® is a well-known product for combating fleas and ticks in dogs and cats. Petmed Express is headquartered in Delray Beach, Florida. The company employs around 430 employees and operates a large distribution center in Pompano Beach, Florida. In summary, Petmed Express' business model is focused on the online sale of veterinary medications and products, as well as collaborating with veterinarians. The company offers its customers a wide range of products, fast delivery, free shipping, a loyalty program, and an easy return and refund policy. Additionally, the company works closely with animal organizations and veterinarians to support animal welfare and rescue efforts.
The revenue of Petmed Express is 179.02 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Petmed Express is -57.29 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Petmed Express is currently -0.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Petmed Express stock.
The price-to-sales ratio (P/S) of Petmed Express is currently 0.15. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Petmed Express stock.
The Eulerpool Quality Score for Petmed Express is 1/10.
The ISIN of Petmed Express is US7163821066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Petmed Express is 121843. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Petmed Express is PETS. The ticker symbol is used to trade Petmed Express shares on the stock exchange.
Petmed Express stock
Petmed Express Peer Group
Petmed Express Ticker
Petmed Express FIGI
All fundamentals and in-depth analysis of Petmed Express
Our stock analysis for Petmed Express stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Petmed Express. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.